Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,063.00p on 30-03-2026 at 19:16:22
Change 14.00p 0.68%
Buy 2,057.00p
Sell 2,056.00p
Last Trade: Buy 1,030.00 at 2,063.00p
Day's Volume: 9,872,668
Last Close: 2,063.00p
Open: 2,051.00p
ISIN: GB00BN7SWP63
Day's Range 2,044.00p - 2,070.00p
52wk Range: 1,242.50p - 2,282.00p
Market Capitalisation: £82.50b
VWAP: 2,059.28711p
Shares in Issue: 4.00b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,030 2,063.00p SI Trade
Negotiated Trade
16:50:08 - 30-Mar-26
Buy* 3,118 2,063.00p SI Trade
Negotiated Trade
16:50:08 - 30-Mar-26
Sell* 347 2,061.965p SI Trade
Suspected SELL Trade
16:39:23 - 30-Mar-26
Buy* 700 2,063.00p Automatic Execution
16:35:27 - 30-Mar-26
Buy* 1,300 2,063.00p Automatic Execution
16:35:27 - 30-Mar-26
Buy* 5 2,063.00p SI Trade
16:35:17 - 30-Mar-26
Buy* 545 2,063.00p SI Trade
16:35:17 - 30-Mar-26
Buy* 23 2,063.00p SI Trade
16:35:17 - 30-Mar-26
Buy* 249 2,063.00p SI Trade
16:35:17 - 30-Mar-26
Buy* 40,002 2,063.00p SI Trade
16:35:17 - 30-Mar-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Mar 2026 (Mon) 2,051.00 2,070.00 2,044.00 2,063.00 9,872,668
27th Mar 2026 (Fri) 2,041.00 2,060.00 2,023.00 2,049.00 6,240,777
26th Mar 2026 (Thu) 2,035.00 2,072.00 2,035.00 2,047.00 12,704,366
25th Mar 2026 (Wed) 1,991.50 2,054.00 1,989.50 2,054.00 11,609,628
24th Mar 2026 (Tue) 1,943.50 1,977.00 1,933.00 1,977.00 7,832,345
23rd Mar 2026 (Mon) 1,926.00 1,966.50 1,906.50 1,937.00 12,420,260
20th Mar 2026 (Fri) 1,960.00 1,967.50 1,940.50 1,950.50 14,988,054
19th Mar 2026 (Thu) 1,951.50 1,976.00 1,943.50 1,956.00 7,174,578
18th Mar 2026 (Wed) 2,010.00 2,013.00 1,945.50 1,972.50 8,290,930
17th Mar 2026 (Tue) 2,032.00 2,037.00 2,002.00 2,013.00 11,964,583
16th Mar 2026 (Mon) 2,037.00 2,053.00 2,026.00 2,026.00 6,815,220
13th Mar 2026 (Fri) 2,029.00 2,062.00 2,027.00 2,031.00 8,608,847
12th Mar 2026 (Thu) 2,053.00 2,057.00 2,015.00 2,031.00 7,904,164
11th Mar 2026 (Wed) 2,063.00 2,077.00 2,046.00 2,066.00 4,932,959
10th Mar 2026 (Tue) 2,067.00 2,085.00 2,052.00 2,064.00 9,406,603
9th Mar 2026 (Mon) 1,994.00 2,051.00 1,987.50 2,046.00 9,595,185
6th Mar 2026 (Fri) 2,080.00 2,080.00 2,028.00 2,038.00 5,641,142
5th Mar 2026 (Thu) 2,114.00 2,135.00 2,072.00 2,076.00 8,766,502
4th Mar 2026 (Wed) 2,125.00 2,149.00 2,110.00 2,115.00 6,322,356
3rd Mar 2026 (Tue) 2,165.00 2,171.00 2,115.00 2,122.00 6,689,092
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
30th Mar 2026 7:05 am RNS Bepirovirsen accepted for review in China
30th Mar 2026 7:00 am RNS Exdensur approved for severe asthma in China
30th Mar 2026 7:00 am RNS Transaction in Own Shares
27th Mar 2026 7:00 am RNS Bepirovirsen accepted for review by the EMA
27th Mar 2026 7:00 am RNS Transaction in Own Shares
26th Mar 2026 7:00 am RNS Transaction in Own Shares
25th Mar 2026 3:30 pm RNS Director/PDMR Shareholding
25th Mar 2026 1:00 pm RNS Notice of AGM
25th Mar 2026 7:00 am RNS Transaction in Own Shares
24th Mar 2026 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET OPEN: FTSE 100 higher as oil, mining stocks climb

30th Mar 2026 09:10

(Alliance News) - Stock prices in London opened mixed on Monday, ahead of UK mortgage approvals data and as the US and Iran's contrasting statements on the ongoing conflict continue. Read More

GSK shares rise on regulatory momentum for two drugs in China

30th Mar 2026 09:05

(Alliance News) - GSK PLC on Monday reported regulatory momentum in China for its drugs Exdensur and bepirovirsen. Read More

European Medicine Agency to review GSK's chronic hepatitis B treatment

27th Mar 2026 08:38

(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepirovirsen. Read More

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

27th Mar 2026 07:56

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More

WINNERS & LOSERS: Next climbs; Ceres jumps on Centrica deal

26th Mar 2026 10:46

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,127.96
Change160.61

Login to your account

Forgot Password?

Not Registered